Last 12 months
Inside the activity.
1 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 13 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 04, 2021 Filed Jan 6, 2021 16:37 UTC |
MORNEAU MICHAELVP, Finance and Administration
|
GrantStock Option (Right to Buy) · Derivative | 33,000 | $0.00 Strike: $5.80 | $0.00 |
DisclosureSEC source: 0001209191-21-002114 · doc4.xml · derivative · entry 4 MORNEAU MICHAEL · CIK 0001517780 · VP, Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,000 shares Expires 2031-01-04 F5 · derivative.exercise_date: 25% of the shares subject to the option will vest on each anniversary of the grant date. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:37 UTC |
MORNEAU MICHAELVP, Finance and Administration
|
Tax withholdingCommon Stock, par value $0.00001 per share | 2,739 | $5.80 | $15,886.20 |
DisclosureSEC source: 0001209191-21-002114 · doc4.xml · nonDerivative · entry 3 MORNEAU MICHAEL · CIK 0001517780 · VP, Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,747 F4 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to performance restricted stock unit award. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:37 UTC |
MORNEAU MICHAELVP, Finance and Administration
|
GrantCommon Stock, par value $0.00001 per share | 6,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002114 · doc4.xml · nonDerivative · entry 2 MORNEAU MICHAEL · CIK 0001517780 · VP, Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,486 F3 · shares: The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2019, 33.33% of which vested on January 4, 2021 upon the achievement of a non-financial performance goal. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:37 UTC |
MORNEAU MICHAELVP, Finance and Administration
|
GrantCommon Stock, par value $0.00001 per share | 14,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002114 · doc4.xml · nonDerivative · entry 1 MORNEAU MICHAEL · CIK 0001517780 · VP, Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,819 F1 · shares: Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award. F2 · balance_after: Includes 1,279 shares acquired on November 20, 2020 pursuant to the Issuer's 2014 Employee Stock Purchase Plan. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:41 UTC |
MACARTNEY LAWSONDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $5.80 | $0.00 |
DisclosureSEC source: 0001209191-21-002135 · doc4.xml · derivative · entry 1 MACARTNEY LAWSON · CIK 0001606831 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2031-01-04 Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:38 UTC |
Rouan Sarah KathrynDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $5.80 | $0.00 |
DisclosureSEC source: 0001209191-21-002119 · doc4.xml · derivative · entry 1 Rouan Sarah Kathryn · CIK 0001761366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2031-01-04 Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:34 UTC |
Lian BrianDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 369,000 | $0.00 Strike: $5.80 | $0.00 |
DisclosureSEC source: 0001209191-21-002104 · doc4.xml · derivative · entry 5 Lian Brian · CIK 0001614578 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,000 Underlying: Common Stock · 369,000 shares Expires 2031-01-04 F6 · derivative.exercise_date: 25% of the shares subject to the option will vest on each anniversary of the grant date. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:34 UTC |
Lian BrianDirector · President & CEO
|
Tax withholdingCommon Stock, par value $0.00001 per share | 16,973 | $5.80 | $98,443.40 |
DisclosureSEC source: 0001209191-21-002104 · doc4.xml · nonDerivative · entry 4 Lian Brian · CIK 0001614578 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,899,792 F5 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to a performance restricted stock unit award. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:34 UTC |
Lian BrianDirector · President & CEO
|
GrantCommon Stock, par value $0.00001 per share | 40,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002104 · doc4.xml · nonDerivative · entry 3 Lian Brian · CIK 0001614578 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,916,765 F4 · shares: The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2019, 33.33% of which vested on January 4, 2021 upon the achievement of a non-financial performance goal. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:34 UTC |
Lian BrianDirector · President & CEO
|
GrantCommon Stock, par value $0.00001 per share | 164,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002104 · doc4.xml · nonDerivative · entry 2 Lian Brian · CIK 0001614578 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,876,432 F3 · shares: Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:26 UTC |
Mancini MariannaChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $5.80 | $0.00 |
DisclosureSEC source: 0001209191-21-002074 · doc4.xml · derivative · entry 4 Mancini Marianna · CIK 0001838112 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2031-01-04 F4 · derivative.exercise_date: One-third of the shares subject to the option will vest on each anniversary of the grant date. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:26 UTC |
Mancini MariannaChief Operating Officer
|
Tax withholdingCommon Stock, par value $0.00001 per share | 2,773 | $5.80 | $16,083.40 |
DisclosureSEC source: 0001209191-21-002074 · doc4.xml · nonDerivative · entry 3 Mancini Marianna · CIK 0001838112 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,632 F3 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to a performance restricted stock unit award. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:26 UTC |
Mancini MariannaChief Operating Officer
|
GrantCommon Stock, par value $0.00001 per share | 6,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002074 · doc4.xml · nonDerivative · entry 2 Mancini Marianna · CIK 0001838112 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,405 F2 · shares: The reported securities were subject to a performance restricted stock unit award that was granted on January 15, 2019, 33.33% of which vested on January 4, 2021 upon the achievement of a non-financial performance goal. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:26 UTC |
Mancini MariannaChief Operating Officer
|
GrantCommon Stock, par value $0.00001 per share | 73,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002074 · doc4.xml · nonDerivative · entry 1 Mancini Marianna · CIK 0001838112 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,655 F1 · shares: Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award. Read SEC document |
| January 03, 2021 Filed Jan 6, 2021 21:34 UTC |
Lian BrianDirector · President & CEO
|
Tax withholdingCommon Stock, par value $0.00001 per share | 31,545 | $5.63 | $177,598.35 |
DisclosureSEC source: 0001209191-21-002104 · doc4.xml · nonDerivative · entry 1 Lian Brian · CIK 0001614578 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,712,432 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units. F2 · balance_after: Includes 1,614 shares acquired on November 20, 2020 pursuant to the Issuer's 2014 Employee Stock Purchase Plan. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 17:21 UTC |
MORNEAU MICHAELVP, Finance and Administration
|
Tax withholdingCommon Stock | 1,557 | $6.25 | $9,731.25 |
DisclosureSEC source: 0001209191-20-050734 · doc4.xml · nonDerivative · entry 2 MORNEAU MICHAEL · CIK 0001517780 · VP, Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,873 F3 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to a performance restricted stock unit award. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 17:21 UTC |
MORNEAU MICHAELVP, Finance and Administration
|
GrantCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-050734 · doc4.xml · nonDerivative · entry 1 MORNEAU MICHAEL · CIK 0001517780 · VP, Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,430 F1 · shares: The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2020, 33.33% of which vested on September 15, 2020 upon the achievement of a non-financial performance goal. F2 · balance_after: Includes 2,090 shares acquired on May 20, 2020 pursuant to the Issuer's 2014 Employee Stock Purchase Plan. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 21:18 UTC |
Lian BrianDirector · President & CEO
|
Tax withholdingCommon Stock | 19,192 | $6.25 | $119,950.00 |
DisclosureSEC source: 0001209191-20-050732 · doc4.xml · nonDerivative · entry 2 Lian Brian · CIK 0001614578 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,742,363 F3 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to a performance restricted stock unit award. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 21:18 UTC |
Lian BrianDirector · President & CEO
|
GrantCommon Stock | 55,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-050732 · doc4.xml · nonDerivative · entry 1 Lian Brian · CIK 0001614578 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,761,555 F1 · shares: The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2020, 33.33% of which vested on September 15, 2020 upon the achievement of a non-financial performance goal. F2 · balance_after: Includes 1,743 shares acquired on May 20, 2020 pursuant to the Issuer's 2014 Employee Stock Purchase Plan. Read SEC document |
| August 26, 2020 Filed Aug 27, 2020 23:06 UTC |
LIGAND PHARMACEUTICALS INC10% owner
|
SaleCommon Stock | 94,488 | $8.11 | $766,108.70 |
DisclosureSEC source: 0000899243-20-023546 · doc4.xml · nonDerivative · entry 2 LIGAND PHARMACEUTICALS INC · CIK 0000886163 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,819,383 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.0948 to $8.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Includes 882,474 shares of Common Stock held by Metabasis Therapeutics, Inc., a wholly owned subsidiary of the Reporting Person. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 21:11 UTC Amendment |
LIGAND PHARMACEUTICALS INC10% owner
|
SaleCommon Stock | 148,700 | $8.11 | $1,205,659.60 |
DisclosureSEC source: 0000899243-20-023644 · doc4a.xml · nonDerivative · entry 1 LIGAND PHARMACEUTICALS INC · CIK 0000886163 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,819,383 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.0948 to $8.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Includes 882,474 shares of Common Stock held by Metabasis Therapeutics, Inc., a wholly owned subsidiary of the Reporting Person. Read SEC document |
| August 25, 2020 Filed Aug 27, 2020 23:06 UTC |
LIGAND PHARMACEUTICALS INC10% owner
|
SaleCommon Stock | 70,000 | $8.02 | $561,575.00 |
DisclosureSEC source: 0000899243-20-023546 · doc4.xml · nonDerivative · entry 1 LIGAND PHARMACEUTICALS INC · CIK 0000886163 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,968,083 F1 · balance_after: Includes 882,474 shares of Common Stock held by Metabasis Therapeutics, Inc., a wholly owned subsidiary of the Reporting Person. Read SEC document |
| June 30, 2020 Filed Jun 30, 2020 21:54 UTC |
FOEHR MATTHEW WDirector
|
SaleCommon Stock, par value $0.00001 per share | 13,000 | $7.35 | $95,550.00 |
DisclosureSEC source: 0001209191-20-039521 · doc4.xml · nonDerivative · entry 1 FOEHR MATTHEW W · CIK 0001237556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Read SEC document |
| March 31, 2020 Filed Apr 3, 2020 17:47 UTC |
MORNEAU MICHAELVP, Finance and Administration
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001209191-20-023378 · doc4.xml · derivative · entry 1 MORNEAU MICHAEL · CIK 0001517780 · VP, Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-03-31 F1 · derivative.exercise_date: 25% of the shares subject to the option will vest on each anniversary of the grant date. Read SEC document |
| January 19, 2020 Filed Jan 21, 2020 17:35 UTC |
MORNEAU MICHAELVP, Finance and Administration
|
Tax withholdingCommon Stock, par value $0.00001 per share | 2,044 | $7.18 | $14,675.92 |
DisclosureSEC source: 0001209191-20-004311 · doc4.xml · nonDerivative · entry 1 MORNEAU MICHAEL · CIK 0001517780 · VP, Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,840 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units. F2 · balance_after: Includes 2,893 shares acquired on May 20, 2019 and November 20, 2019 pursuant to the Issuer's 2014 Employee Stock Purchase Plan. Read SEC document |
| January 19, 2020 Filed Jan 21, 2020 22:39 UTC |
Lian BrianDirector · President & CEO
|
Tax withholdingCommon Stock, par value $0.00001 per share | 3,195 | $7.18 | $22,940.10 |
DisclosureSEC source: 0001209191-20-004314 · doc4.xml · nonDerivative · entry 1 Lian Brian · CIK 0001614578 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,704,312 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units. Read SEC document |
| January 03, 2020 Filed Jan 3, 2020 20:03 UTC |
MORNEAU MICHAELVP, Finance and Administration
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001209191-20-001428 · doc4.xml · derivative · entry 1 MORNEAU MICHAEL · CIK 0001517780 · VP, Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2030-01-03 F1 · derivative.exercise_date: 25% of the shares subject to the option will vest on each anniversary of the grant date. Read SEC document |
| January 03, 2020 Filed Jan 4, 2020 01:01 UTC |
Lian BrianDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 345,000 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001209191-20-001426 · doc4.xml · derivative · entry 3 Lian Brian · CIK 0001614578 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,000 Underlying: Common Stock · 345,000 shares Expires 2030-01-03 F4 · derivative.exercise_date: 25% of the shares subject to the option will vest on each anniversary of the grant date. Read SEC document |
| January 03, 2020 Filed Jan 4, 2020 01:01 UTC |
Lian BrianDirector · President & CEO
|
Tax withholdingCommon Stock, par value $0.00001 per share | 6,782 | $7.77 | $52,696.14 |
DisclosureSEC source: 0001209191-20-001426 · doc4.xml · nonDerivative · entry 2 Lian Brian · CIK 0001614578 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,707,507 F3 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units. Read SEC document |
| January 03, 2020 Filed Jan 4, 2020 01:01 UTC |
Lian BrianDirector · President & CEO
|
GrantCommon Stock, par value $0.00001 per share | 153,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-001426 · doc4.xml · nonDerivative · entry 1 Lian Brian · CIK 0001614578 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,714,289 F1 · shares: Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award. F2 · balance_after: Includes 804 shares acquired on May 20, 2019 and November 20, 2019 pursuant to the Issuer's 2014 Employee Stock Purchase Plan. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 01:01 UTC |
Webster Stephen WDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $7.95 | $0.00 |
DisclosureSEC source: 0001209191-20-001425 · doc4.xml · derivative · entry 1 Webster Stephen W · CIK 0001438421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2030-01-02 Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 19:59 UTC |
SINGLETON J MATTHEWDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $7.95 | $0.00 |
DisclosureSEC source: 0001209191-20-001422 · doc4.xml · derivative · entry 1 SINGLETON J MATTHEW · CIK 0001243514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2030-01-02 Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 00:59 UTC |
FOEHR MATTHEW WDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $7.95 | $0.00 |
DisclosureSEC source: 0001209191-20-001421 · doc4.xml · derivative · entry 1 FOEHR MATTHEW W · CIK 0001237556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2030-01-02 Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 19:55 UTC |
Rowland Charles A JrDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $7.95 | $0.00 |
DisclosureSEC source: 0001209191-20-001419 · doc4.xml · derivative · entry 1 Rowland Charles A Jr · CIK 0001383292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2030-01-02 Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 19:57 UTC |
MACARTNEY LAWSONDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $7.95 | $0.00 |
DisclosureSEC source: 0001209191-20-001420 · doc4.xml · derivative · entry 1 MACARTNEY LAWSON · CIK 0001606831 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2030-01-02 Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 00:54 UTC |
Rouan Sarah KathrynDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $7.95 | $0.00 |
DisclosureSEC source: 0001209191-20-001418 · doc4.xml · derivative · entry 1 Rouan Sarah Kathryn · CIK 0001761366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2030-01-02 Read SEC document |
| October 31, 2019 Filed Oct 31, 2019 18:27 UTC |
MORNEAU MICHAELVP, Finance and Administration
|
GrantStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $6.47 | $0.00 |
DisclosureSEC source: 0001209191-19-054654 · doc4.xml · derivative · entry 1 MORNEAU MICHAEL · CIK 0001517780 · VP, Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2029-10-31 F1 · derivative.exercise_date: 25% of the shares subject to the option will vest on each anniversary of the grant date. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 17:59 UTC |
MORNEAU MICHAELVP, Finance and Administration
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $7.69 | $0.00 |
DisclosureSEC source: 0001209191-19-044336 · doc4.xml · derivative · entry 1 MORNEAU MICHAEL · CIK 0001517780 · VP, Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-07-31 F1 · derivative.exercise_date: 1/3 of the shares subject to the option will vest on each anniversary of the grant date. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:20 UTC |
Rouan Sarah KathrynDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001209191-19-040272 · doc4.xml · derivative · entry 1 Rouan Sarah Kathryn · CIK 0001761366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2029-07-01 Read SEC document |
| January 19, 2019 Filed Jan 22, 2019 19:13 UTC |
MORNEAU MICHAELVP, Finance and Administration
|
Tax withholdingCommon Stock, par value $0.00001 per share | 2,044 | $8.78 | $17,946.32 |
DisclosureSEC source: 0001209191-19-004861 · doc4.xml · nonDerivative · entry 1 MORNEAU MICHAEL · CIK 0001517780 · VP, Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,991 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units. Read SEC document |
| January 19, 2019 Filed Jan 23, 2019 00:13 UTC |
Lian BrianDirector · President & CEO
|
Tax withholdingCommon Stock, par value $0.00001 per share | 4,333 | $8.78 | $38,043.74 |
DisclosureSEC source: 0001209191-19-004858 · doc4.xml · nonDerivative · entry 1 Lian Brian · CIK 0001614578 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,560,152 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units. Read SEC document |
| January 03, 2019 Filed Jan 3, 2019 20:33 UTC |
Masamune HirokoChief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 66,000 | $0.00 Strike: $7.58 | $0.00 |
DisclosureSEC source: 0001209191-19-001571 · doc4.xml · derivative · entry 2 Masamune Hiroko · CIK 0001745341 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,000 Underlying: Common Stock · 66,000 shares Expires 2029-01-03 F3 · derivative.exercise_date: 25% of the shares subject to the option will vest on each anniversary of the grant date. Read SEC document |
| January 03, 2019 Filed Jan 3, 2019 20:33 UTC |
Masamune HirokoChief Development Officer
|
GrantCommon Stock, par value $0.00001 per share | 22,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-001571 · doc4.xml · nonDerivative · entry 1 Masamune Hiroko · CIK 0001745341 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,063 F1 · shares: Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. 25% of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award. F2 · balance_after: Includes 7,199 shares acquired on November 20, 2018 pursuant to the Issuer's 2014 Employee Stock Purchase Plan. Read SEC document |
| January 03, 2019 Filed Jan 3, 2019 20:35 UTC |
MORNEAU MICHAELVP, Finance and Administration
|
GrantStock Option (Right to Buy) · Derivative | 29,000 | $0.00 Strike: $7.58 | $0.00 |
DisclosureSEC source: 0001209191-19-001575 · doc4.xml · derivative · entry 1 MORNEAU MICHAEL · CIK 0001517780 · VP, Finance and Administration 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 Underlying: Common Stock · 29,000 shares Expires 2029-01-03 F1 · derivative.exercise_date: 25% of the shares subject to the option will vest on each anniversary of the grant date. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 01:31 UTC |
Lian BrianDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 235,554 | $0.00 Strike: $7.58 | $0.00 |
DisclosureSEC source: 0001209191-19-001568 · doc4.xml · derivative · entry 2 Lian Brian · CIK 0001614578 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,554 Underlying: Common Stock · 235,554 shares Expires 2029-01-03 F3 · derivative.exercise_date: 25% of the shares subject to the option will vest on each anniversary of the grant date. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 01:31 UTC |
Lian BrianDirector · President & CEO
|
GrantCommon Stock, par value $0.00001 per share | 80,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-001568 · doc4.xml · nonDerivative · entry 1 Lian Brian · CIK 0001614578 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,564,485 F1 · shares: Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. 25% of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award. F2 · balance_after: Includes 576 shares acquired on November 20, 2018 pursuant to the Issuer's 2014 Employee Stock Purchase Plan. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 01:28 UTC |
Webster Stephen WDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001209191-19-001566 · doc4.xml · derivative · entry 1 Webster Stephen W · CIK 0001438421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2029-01-02 Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 20:27 UTC |
SINGLETON J MATTHEWDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001209191-19-001564 · doc4.xml · derivative · entry 1 SINGLETON J MATTHEW · CIK 0001243514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2029-01-02 Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 01:26 UTC |
FOEHR MATTHEW WDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001209191-19-001563 · doc4.xml · derivative · entry 1 FOEHR MATTHEW W · CIK 0001237556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2029-01-02 Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 20:20 UTC |
Rowland Charles A JrDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001209191-19-001558 · doc4.xml · derivative · entry 1 Rowland Charles A Jr · CIK 0001383292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2029-01-02 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.